N Perrin1, D H Bodicoat2, M J Davies2, N Robertson3, F J Snoek4, K Khunti2. 1. Division of Rural Health and Wellbeing, University of the Highlands and Islands, Centre for Health Science, Old Perth Road, Inverness, IV2 3JH, United Kingdom. Electronic address: nikki.perrin@uhi.ac.uk. 2. Diabetes Research Centre, University of Leicester, Leicester, United Kingdom. 3. School of Psychology, University of Leicester, Leicester, United Kingdom. 4. Department of Medical Psychology, VU University Medical Centre, Department of Medical Psychology, Academic Medical centre, Amsterdam, Netherlands.
Abstract
AIMS: Psychological comorbidity, such as depression and/or diabetes-specific emotional distress (DSD), is highly prevalent in people with type 2 diabetes (T2DM) and associated with poorer treatment outcomes. While treatments for depression are well established, interventions specifically designed for DSD are sparse. The aim of this study was to determine interventions that successfully address DSD and HbA1c in people with T2DM. METHODS: Seven databases were searched to identify potentially relevant studies. Eligible studies were selected and appraised independently by two reviewers. Multiple meta-analyses and meta-regression analyses were performed to synthesise the data; the primary analyses determined the effect of interventions on DSD, with secondary analyses assessing the effect on HbA1c. RESULTS: Thirty-two studies (n = 5206) provided sufficient DSD data, of which 23 (n = 3818) reported data for HbA1c. Meta-analyses demonstrated that interventions significantly reduced DSD (p = 0.034) and HbA1c (p = 0.006) compared to controls, although subgroup meta-analyses and meta-regression to explore specific intervention characteristics that might mediate this effect yielded non-significant findings. CONCLUSIONS: The findings demonstrate that existing interventions successfully reduce DSD and HbA1c in people with T2DM. While promising, deductions should be interpreted tentatively, highlighting a stark need for further focused exploration of how best to treat psychological comorbidity in people with T2DM.
AIMS: Psychological comorbidity, such as depression and/or diabetes-specific emotional distress (DSD), is highly prevalent in people with type 2 diabetes (T2DM) and associated with poorer treatment outcomes. While treatments for depression are well established, interventions specifically designed for DSD are sparse. The aim of this study was to determine interventions that successfully address DSD and HbA1c in people with T2DM. METHODS: Seven databases were searched to identify potentially relevant studies. Eligible studies were selected and appraised independently by two reviewers. Multiple meta-analyses and meta-regression analyses were performed to synthesise the data; the primary analyses determined the effect of interventions on DSD, with secondary analyses assessing the effect on HbA1c. RESULTS: Thirty-two studies (n = 5206) provided sufficient DSD data, of which 23 (n = 3818) reported data for HbA1c. Meta-analyses demonstrated that interventions significantly reduced DSD (p = 0.034) and HbA1c (p = 0.006) compared to controls, although subgroup meta-analyses and meta-regression to explore specific intervention characteristics that might mediate this effect yielded non-significant findings. CONCLUSIONS: The findings demonstrate that existing interventions successfully reduce DSD and HbA1c in people with T2DM. While promising, deductions should be interpreted tentatively, highlighting a stark need for further focused exploration of how best to treat psychological comorbidity in people with T2DM.
Authors: Marie Dahl; Susanne Friis Søndergaard; Axel Diederichsen; Frans Pouwer; Susanne S Pedersen; Jens Søndergaard; Jes Lindholt Journal: BMC Public Health Date: 2021-01-22 Impact factor: 3.295
Authors: Jia Guo; Hongjuan Wang; Jiaxin Luo; Yi Guo; Yun Xie; Beimei Lei; James Wiley; Robin Whittemore Journal: BMJ Open Diabetes Res Care Date: 2019-12-11